Alycia Kay Halladay
Alma materRutgers University
OccupationScience researcher
Known forAutism research, Autism Science Foundation
Scientific career
FieldsBiological psychiatry
InstitutionsAutism Science Foundation
ThesisInteraction of changes in dopamine signaling and expression of the Eph family tyrosine kinase receptors in mice (2001)

Alycia Kay Halladay is Chief Science Officer at the Autism Science Foundation. Until 2014, she served as the senior director of environmental and clinical sciences for Autism Speaks. She originally joined the National Alliance for Autism Research in 2005 before it merged with Autism Speaks, and was named the associate director of research for environmental sciences in 2007.[1] She also serves at an adjunct professor in the Pharmacology and Toxicology Department at Rutgers University.

Education

After obtaining her bachelor's degree from the University of Texas at Austin, Halladay received her M.S. (1998) and Ph.D. (2001) in psychology, both from Rutgers University, where she completed a postdoctoral fellowship in pharmacology and toxicology.[2]

Autism

At the Autism Science Foundation, Halladay leads the science program of ASF, which includes pre and post doctoral fellowships, accelerator grants, as well as large scale projects including the Autism Sisters Project the outreach and communications behind the Autism BrainNet. She also has experience managing consortium and multidisciplinary initiatives such as gene/environment interactions initiative, the High Risk Baby Siblings Consortium and the Toddler Treatment Network.[3] She was interviewed by Parade magazine in 2013, saying, "There are likely thousands of genes that contribute to risk. However, there are also some environmental factors that contribute to risk. These include maternal infection and certain chemical and medical exposures."[4] She has also said that early intervention "can make a real lifetime of difference"[5] with regard to improving symptoms of autism in children, and after a study on folic acid and autism was published in JAMA, Halladay said that taking folic acid during pregnancy was "a relatively inexpensive way that parents can take action to possibly prevent risk of tube birth defects and autism".[6]

References

  1. ↑ Lajonchere, Clara (16 April 2007). "Autism Speaks™ Announces New Staff Structure for its Science Program". Autism Speaks. Retrieved 16 November 2013.
  2. ↑ "IACC Full Committee Meeting Speaker/Discussant Biographies - July 9, 2013". IACC. 2013-07-09. Retrieved 2014-01-05.
  3. ↑ "Environmental Epigenetics Symposium: About". www.autismepigenetics.org. Autism Epigenetics. Retrieved 25 December 2013.
  4. ↑ Marquez, Jennifer Rainey (29 April 2013). "Your Autism Questions—Answered!". Parade. Retrieved 15 November 2013.
  5. ↑ Sifferlin, Alexandra (20 August 2013). "Siblings of Autistic Children at a Higher Risk for the Disorder; Can That Risk Be Lowered?". Time. Retrieved 15 November 2013.
  6. ↑ Pearson, Catherine (12 February 2013). "Folic Acid Lowers Autism Risk By 40 Percent: Study". Huffington Post. Retrieved 15 November 2013.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.